Ibarra, del Paso y Gallego

The medium-sized firm Ibarra, del Paso y Gallego  has ‘has a specialisation in life sciences and it shows in the highly complex level of consulting they provide��, clients suggest, also noting that it ’has grown considerably in this area in recent years’. The experienced, eight-strong team provides comprehensive legal advisory across the entire array of life science segments, from research and development, agricultural, pharmaceutical, industrial and biotechnology products, through to medical devices, cosmetics and personal care, chemicals, agrochemicals, animal health, tobacco, and food and beverages. Originally more focused on regulatory and sanitary consulting and litigation, the practice has since built-out its IP-side capabilities, giving it additional reach, and today the group handles transactional and regulatory legal advice, life sciences-focused due diligence support, accompaniment in the obtaining of healthcare, biotech and other authorisations; litigation and representation before the Ministry of Health, COFEPRIS and other relevant authorities; and also undertakes risk and contingency assessments in relation to tech transfers, licensing agreements, M&A, joint ventures and export/import matters.  ‘A lawyer who know abouts the life sciences’, name partner and practice co-head Adrián del Paso has approaching two decades focused on environmental, pharmaceutical and health sector matters. He advises both regulated companies and not-for-profit organisations on the full range of regulatory and life science matters and is also an experienced administrative litigator. Fellow co-lead, Juan Manuel Alvarez Del Castillo, who is also head of the intellectual property practice, manages the IP aspects of life science mandates – particularly those related to the pharmaceutical, chemical, technological, and food and beverage industries. Senior associate Mauricio Sandoval is also a key participant as regards administrative litigation; however, the firm will miss the specialist customs and international trade knowledge of dedicated associate Ricardo Koller, who left the firm in late 2022. Since publication, Del Paso and Sandoval have left the firm – effective as of March 2024.